In re Surescripts Antitrust Litigation, No. 1:19-cv-0662 (N.D. Ill.)
$49,750,000 in Settlements.
Proof of Claim Submission Deadline of November 28, 2025.
- This is a class action lawsuit in which Plaintiffs have alleged, among other things, that defendants Surescripts, LLC, Allscripts Healthcare Solutions, Inc., and previously settled defendant RelayHealth entered into a contract, combination, or conspiracy in restraint of trade, the purpose and effect of which was to suppress competition and to charge supracompetitive prices to the Settlement Class during the Class Period, in violation of Sections 1 and 2 of the Sherman Act, 15 U.S.C. §§ 1 and 2 and state antitrust laws.
- Plaintiffs have reached a Settlement with Defendants Surescripts and Allscripts for $39,750,000. The Parties desire to fully and finally settle all actual and potential Claims by Plaintiffs against Surescripts and Allscripts (“Settling Defendants”) arising from or relating to the Action, the factual allegations underlying the Action, and avoid the costs and risks of protracted litigation and trial.
- The Court previously approved a settlement with Defendant RelayHealth on February 22, 2022, for $10,000,000.
- Settling Defendants have denied and continue to deny each and all of the claims and contentions alleged in the Action, or that could have been alleged in the Action, and have moved for summary judgment on Plaintiffs’ claims, and would assert numerous defenses to Plaintiffs’ claims if required to do so.
- For purposes of this Settlement, the Settlement Class includes: All pharmacies in the United States and its territories who paid for e-prescriptions routed through the Surescripts network during the period September 21, 2010 through July 18, 2025. Excluded from the Settlement Class are Defendants and any of their owners, officers, directors, management, employees, subsidiaries, affiliates, legal representatives, heirs, or assigns; any entity in which any Defendant has a financial interest; any entity which has a financial interest in Surescripts; all governmental entities; any judicial officer presiding over this action and the members of his or her immediate family and judicial staff; and any other Defendant or Co-Conspirator identified in this action.
- The Settlement offers cash payments to Settlement Class Members who file valid, timely Claims.
- A portion of the Settlement’s proceeds will be used by the Settlement Administrator to distribute notice and administer the Settlement, including the claims process and distributing funds to eligible claimants. As described below, Plaintiffs will also apply for an award of attorneys’ fees, reimbursement of litigation costs and expenses, and service awards to be paid from the Settlement’s proceeds, subject to Court approval.
- The remainder of the Settlement’s proceeds, plus proceeds from the RelayHealth settlement (less administration costs) will be available for distribution to Settlement Class Members who file valid and timely claims. The Class Period for this Settlement is September 21, 2010 through July 18, 2025. The Class Period for the prior RelayHealth settlement was different: September 21, 2010 through April 19, 2021. If you already submitted a claim in connection with the prior RelayHealth settlement, you have the option of submitting additional information for the period April 20, 2021 through July 18, 2025.